Searched for
MANKIND PHARMA SHARE PRICE
Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- 5 stocks with consistent score improvement and upside potential of up to 30% in 1 year, according to analystsWhen the profit a company is expected to earn gets marked down, the price the market will pay for its stock has to come down too. That has ...
- Coforge slips 3% even as Jefferies, Nomura, others raise targets after Q2 earnings. Why are they bullish?Coforge shares fell despite strong Q2 results and brokerages raising target prices. Net profit surged 56.5% year-on-year to Rs 588.1 crore,...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Two Trades for Today: A digital tech solutions company for a 5.4% rise, a top pharma stock for an almost 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Tourism is the sector the market writes off in a downturn. Is it indicating something else? 7 stocks with upside potential of up to 27%For years the street has believed that when the economy slows, tourism and hotels are the first to feel it. The logic: A hotel stay is not ...
- Indian pharma: Unethical practices, marketing rules under lens; new review body set upThe review comes against the backdrop of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which was introduced in 2015 as a...
- Bharat Electronics among 4 Sensex stocks to hit 52-week lows; shares fall up to 9% in a monthFour Sensex stocks, including Bharat Electronics, NTPC, Power Grid Corporation and Hindustan Unilever, touched fresh 52-week lows on Friday...
- Swiggy shares crash 14%, hit 52-week low after Q2 results. Here’s why Jefferies, Nomura, Bernstein cut target priceSwiggy Share Price: Swiggy experienced a notable decline in share prices after announcing a Rs 922 crore loss for the quarter. Revenue from...
- Two Trades for Today: A top pharma company for a 6.3% upmove, a large-cap hospitality stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%What should you focus on when headwinds blow? Not the share price, and not the morning's news. It should be the business and the quality of...
- Sky Gold and Diamonds among 5 stocks that hit 52-week highs and rallied up to 45% in a monthDespite the Sensex falling 143 points on Wednesday, five BSE 1000 stocks hit fresh 52-week highs. PC Jeweller led monthly gains at 45%, fol...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- 5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
Load More
